{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T07:46:11Z","timestamp":1740123971022,"version":"3.37.3"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2018,9,19]],"date-time":"2018-09-19T00:00:00Z","timestamp":1537315200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100009947","name":"Merck Sharp and Dohme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009947","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Assist Reprod Genet"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1007\/s10815-018-1314-2","type":"journal-article","created":{"date-parts":[[2018,9,19]],"date-time":"2018-09-19T00:10:17Z","timestamp":1537315817000},"page":"2187-2193","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Concentration of soluble urokinase plasminogen activator receptor (suPAR) in the pre-ovulatory follicular fluid is associated with development of ovarian hyperstimulation syndrome during ovarian stimulation"],"prefix":"10.1007","volume":"35","author":[{"given":"A. G.","family":"Grynnerup","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Toftager","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Zedeler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.W.","family":"Bogstad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Pr\u00e6torius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. L.","family":"Gr\u00f8ndahl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Yding Andersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"S\u00f8rensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Pinborg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"L\u00f8ssl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,9,19]]},"reference":[{"key":"1314_CR1","doi-asserted-by":"publisher","first-page":"70","DOI":"10.4103\/0974-1208.86080","volume":"4","author":"P Kumar","year":"2011","unstructured":"Kumar P, Sait SF, Sharma A, Kumar M. Ovarian hyperstimulation syndrome. J Hum Reprod Sci. 2011;4:70\u20135.","journal-title":"J Hum Reprod Sci"},{"key":"1314_CR2","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1097\/00006254-198906000-00004","volume":"44","author":"A Golan","year":"1989","unstructured":"Golan A, Ron-el R, Herman A, Soffer Y, Weinraub Z, Caspi E. Ovarian hyperstimulation syndrome: an update review. Obstet Gynecol Surv. 1989;44:430\u201340.","journal-title":"Obstet Gynecol Surv"},{"key":"1314_CR3","first-page":"S188","volume":"90","author":"Practice Committee of American Society for Reproductive Medicine","year":"2008","unstructured":"Practice Committee of American Society for Reproductive Medicine. Ovarian hyperstimulation syndrome. Fertil Steril. 2008;90:S188\u201393.","journal-title":"Fertil Steril"},{"key":"1314_CR4","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.ejogrb.2016.10.051","volume":"207","author":"KVM Korhonen","year":"2016","unstructured":"Korhonen KVM, Savolainen-Peltonen HM, Mikkola TS, Tiitinen AE, Unkila-Kallio LS. C-reactive protein response is higher in early than in late ovarian hyperstimulation syndrome. Eur J Obstet Gynecol Reprod Biol. 2016;207:162\u20138.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"1314_CR5","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.jsgi.2004.05.001","volume":"11","author":"R Orvieto","year":"2004","unstructured":"Orvieto R. Controlled ovarian hyperstimulation--an inflammatory state. J Soc Gynecol Investig. 2004;11:424\u20136.","journal-title":"J Soc Gynecol Investig"},{"key":"1314_CR6","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1530\/REP-17-0268","volume":"154","author":"J Zhai","year":"2017","unstructured":"Zhai J, Liu J, Zhao S, Zhao H, Chen Z-J, Du Y, et al. Kisspeptin-10 inhibits OHSS by suppressing VEGF secretion. Reproduction. 2017;154:355\u201362.","journal-title":"Reproduction"},{"key":"1314_CR7","doi-asserted-by":"publisher","first-page":"4699","DOI":"10.1210\/jc.2016-1744","volume":"101","author":"I Miller","year":"2016","unstructured":"Miller I, Chuderland D, Grossman H, Ron-El R, Ben-Ami I, Shalgi R. The dual role of PEDF in the pathogenesis of OHSS: negating both angiogenic and inflammatory pathways. J Clin Endocrinol Metab. 2016;101:4699\u2013709.","journal-title":"J Clin Endocrinol Metab"},{"key":"1314_CR8","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/1477-7827-9-147","volume":"9","author":"EG Papanikolaou","year":"2011","unstructured":"Papanikolaou EG, Humaidan P, Polyzos N, Kalantaridou S, Kol S, Benadiva C, et al. New algorithm for OHSS prevention. Reprod Biol Endocrinol. 2011;9:147.","journal-title":"Reprod Biol Endocrinol"},{"key":"1314_CR9","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1007\/s10815-017-0990-7","volume":"34","author":"TB Tarlatzi","year":"2017","unstructured":"Tarlatzi TB, Venetis CA, Devreker F, Englert Y, Delbaere A. What is the best predictor of severe ovarian hyperstimulation syndrome in IVF? A cohort study. J Assist Reprod Genet. 2017;34:1341\u201351.","journal-title":"J Assist Reprod Genet"},{"key":"1314_CR10","doi-asserted-by":"publisher","first-page":"e0149615","DOI":"10.1371\/journal.pone.0149615","volume":"11","author":"G Griesinger","year":"2016","unstructured":"Griesinger G, Verweij PJM, Gates D, Devroey P, Gordon K, Stegmann BJ, et al. Prediction of ovarian hyperstimulation syndrome in patients treated with corifollitropin alfa or rFSH in a GnRH antagonist protocol. PLoS One. 2016;11:e0149615.","journal-title":"PLoS One"},{"key":"1314_CR11","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.fertnstert.2005.07.1292","volume":"85","author":"EG Papanikolaou","year":"2006","unstructured":"Papanikolaou EG, Pozzobon C, Kolibianakis EM, Camus M, Tournaye H, Fatemi HM, et al. Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles. Fertil Steril. 2006;85:112\u201320.","journal-title":"Fertil Steril"},{"key":"1314_CR12","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/j.fertnstert.2013.12.026","volume":"101","author":"RG Steward","year":"2014","unstructured":"Steward RG, Lan L, Shah AA, Yeh JS, Price TM, Goldfarb JM, et al. Oocyte number as a predictor for ovarian hyperstimulation syndrome and live birth: an analysis of 256,381 in vitro fertilization cycles. Fertil Steril Elsevier Inc. 2014;101:967\u201373.","journal-title":"Fertil Steril"},{"key":"1314_CR13","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1093\/humrep\/dew051","volume":"31","author":"M Toftager","year":"2016","unstructured":"Toftager M, Bogstad J, Bryndorf T, L\u00f8ssl K, Rosk\u00e6r J, Holland T, et al. Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist versus GnRH agonist protocol: RCT including 1050 first IVF\/ICSI cycles. Hum Reprod. 2016;31:1253\u201364.","journal-title":"Hum Reprod"},{"key":"1314_CR14","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1083\/jcb.100.1.86","volume":"100","author":"JD Vassalli","year":"1985","unstructured":"Vassalli JD, Baccino D, Belin D. A cellular binding site for the Mr 55,000 form of the human plasminogen activator, urokinase. J Cell Biol. 1985;100:86\u201392.","journal-title":"J Cell Biol"},{"key":"1314_CR15","doi-asserted-by":"publisher","first-page":"3356","DOI":"10.2741\/1487","volume":"9","author":"Y-X Liu","year":"2004","unstructured":"Liu Y-X. Plasminogen activator\/plasminogen activator inhibitors in ovarian physiology. Front Biosci. 2004;9:3356\u201373.","journal-title":"Front Biosci"},{"key":"1314_CR16","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1155\/2009\/504294","volume":"27","author":"M Thun\u00f8","year":"2009","unstructured":"Thun\u00f8 M, Macho B, Eugen-Olsen J. suPAR: the molecular crystal ball. Dis Markers. 2009;27:157\u201372.","journal-title":"Dis Markers"},{"key":"1314_CR17","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1111\/j.1471-0528.2005.00602.x","volume":"112","author":"I Levin","year":"2005","unstructured":"Levin I, Gamzu R, Pauzner D, Rogowski O, Shapira I, Maslovitz S, et al. Elevated levels of CRP in ovarian hyperstimulation syndrome: an unrecognised potential hazard? BJOG. 2005;112:952\u20135.","journal-title":"BJOG"},{"key":"1314_CR18","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1177\/1933719111428518","volume":"19","author":"RM Lamaita","year":"2012","unstructured":"Lamaita RM, Pontes A, Belo AV, Caetano JPJ, Andrade SP, C\u00e3ndido EB, et al. Inflammatory response patterns in ICSI patients: a comparative study between chronic anovulating and normally ovulating women. Reprod Sci. 2012;19:704\u201311.","journal-title":"Reprod Sci"},{"key":"1314_CR19","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1093\/humupd\/3.3.255","volume":"3","author":"B Rizk","year":"1997","unstructured":"Rizk B, Aboulghar M, Smitz J, Ron-El R. The role of vascular endothelial growth factor and interleukins in the pathogenesis of severe ovarian hyperstimulation syndrome. Hum Reprod Update. 1997;3:255\u201366.","journal-title":"Hum Reprod Update"},{"key":"1314_CR20","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1210\/edrv.18.1.0287","volume":"18","author":"N Ferrara","year":"1997","unstructured":"Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev. 1997;18:4\u201325.","journal-title":"Endocr Rev"},{"key":"1314_CR21","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/S1537-1891(03)00011-9","volume":"39","author":"DO Bates","year":"2002","unstructured":"Bates DO, Harper SJ. Regulation of vascular permeability by vascular endothelial growth factors. Vasc Pharmacol. 2002;39:225\u201337.","journal-title":"Vasc Pharmacol"},{"key":"1314_CR22","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.fertnstert.2010.09.044","volume":"95","author":"M-Z Gao","year":"2011","unstructured":"Gao M-Z, Zhao X-M, Sun Z-G, Hong Y, Zhao L-W, Zhang H-Q. Endocrine gland-derived vascular endothelial growth factor concentrations in follicular fluid and serum may predict ovarian hyperstimulation syndrome in women undergoing controlled ovarian hyperstimulation. Fertil Steril. 2011;95:673\u20138.","journal-title":"Fertil Steril"},{"key":"1314_CR23","first-page":"477","volume":"68","author":"AJ Jakimiuk","year":"2017","unstructured":"Jakimiuk AJ, Nowicka MA, Zagozda M, Koziol K, Lewandowski P, Issat T. High levels of soluble vascular endothelial growth factor receptor 1\/sFlt1 and low levels of vascular endothelial growth factor in follicular fluid on the day of oocyte retrieval correlate with ovarian hyperstimulation syndrome regardless of the stimulation. J Physiol Pharmacol. 2017;68:477\u201384.","journal-title":"J Physiol Pharmacol"},{"key":"1314_CR24","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1016\/S0015-0282(02)04243-7","volume":"78","author":"R Mathur","year":"2002","unstructured":"Mathur R, Hayman G, Bansal A, Jenkins J. Serum vascular endothelial growth factor levels are poorly predictive of subsequent ovarian hyperstimulation syndrome in highly responsive women undergoing assisted conception. Fertil Steril. 2002;78:1154\u20138.","journal-title":"Fertil Steril"},{"key":"1314_CR25","first-page":"91","volume":"44","author":"E Geva","year":"1999","unstructured":"Geva E, Amit A, Lessing JB, Lerner-Geva L, Daniel Y, Yovel I, et al. Follicular fluid levels of vascular endothelial growth factor. Are they predictive markers for ovarian hyperstimulation syndrome? J Reprod Med. 1999;44:91\u20136.","journal-title":"J Reprod Med"},{"key":"1314_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3858\/emm.2012.44.1.025","volume":"44","author":"S Falco De","year":"2012","unstructured":"De Falco S. The discovery of placenta growth factor and its biological activity. Exp Mol Med. 2012;44:1\u20139.","journal-title":"Exp Mol Med"},{"key":"1314_CR27","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1016\/j.fertnstert.2007.03.097","volume":"89","author":"G Gutman","year":"2008","unstructured":"Gutman G, Barak V, Maslovitz S, Amit A, Lessing JB, Geva E. Regulation of vascular endothelial growth factor-A and its soluble receptor sFlt-1 by luteinizing hormone in vivo: implication for ovarian follicle angiogenesis. Fertil Steril. 2008;89:922\u20136.","journal-title":"Fertil Steril"},{"key":"1314_CR28","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/1477-7827-12-82","volume":"12","author":"R Tal","year":"2014","unstructured":"Tal R, Seifer DB, Grazi RV, Malter HE. Follicular fluid placental growth factor is increased in polycystic ovarian syndrome: correlation with ovarian stimulation. Reprod Biol Endocrinol. 2014;12:82.","journal-title":"Reprod Biol Endocrinol"},{"key":"1314_CR29","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1093\/humrep\/dex334","volume":"33","author":"\u00c5 Magnusson","year":"2018","unstructured":"Magnusson \u00c5, K\u00e4llen K, Thurin-Kjellberg A, Bergh C. The number of oocytes retrieved during IVF: a balance between efficacy and safety. Hum Reprod. 2018;33:58\u201364.","journal-title":"Hum Reprod"},{"key":"1314_CR30","first-page":"829","volume":"96","author":"CD Chen","year":"1997","unstructured":"Chen CD, Wu MY, Chao KH, Chen SU, Ho HN, Yang YS. Serum estradiol level and oocyte number in predicting severe ovarian hyperstimulation syndrome. J Formos Med Assoc. 1997;96:829\u201334.","journal-title":"J Formos Med Assoc"},{"key":"1314_CR31","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1093\/oxfordjournals.humrep.a137276","volume":"6","author":"RH Asch","year":"1991","unstructured":"Asch RH, Li HP, Balmaceda JP, Weckstein LN, Stone SC. Severe ovarian hyperstimulation syndrome in assisted reproductive technology: definition of high risk groups. Hum Reprod. 1991;6:1395\u20139.","journal-title":"Hum Reprod"},{"key":"1314_CR32","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1093\/humrep\/14.3.628","volume":"14","author":"C Mendoza","year":"1999","unstructured":"Mendoza C, Cremades N, Ruiz-Requena E, Martinez F, Ortega E, Bernabeu S, et al. Relationship between fertilization results after intracytoplasmic sperm injection, and intrafollicular steroid, pituitary hormone and cytokine concentrations. Hum Reprod. 1999;14:628\u201335.","journal-title":"Hum Reprod"}],"container-title":["Journal of Assisted Reproduction and Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10815-018-1314-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10815-018-1314-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10815-018-1314-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T19:08:26Z","timestamp":1568833706000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10815-018-1314-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,19]]},"references-count":32,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1314"],"URL":"https:\/\/doi.org\/10.1007\/s10815-018-1314-2","relation":{},"ISSN":["1058-0468","1573-7330"],"issn-type":[{"type":"print","value":"1058-0468"},{"type":"electronic","value":"1573-7330"}],"subject":[],"published":{"date-parts":[[2018,9,19]]},"assertion":[{"value":"30 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. For this type of study, formal consent is not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}